newsfilter
← Latest News
PR Newswire·

Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors

Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and...